Our Faculty:

Twenty accomplished academicians anchor the Department bringing deep expertise across Pharmaceutics, Industrial Pharmacy, Quality Assurance, and Regulatory Affairs. The team comprising senior professors with decades of Industrial-collaboration experience, mid-career researchers driving high-impact grants and patents, and energetic early-career scientists introducing data-driven and AI-enabled approaches to formulation science. Collectively they have:

• >500 SCI-indexed publications and multiple national patents in the past five years
• Recognised leadership roles on national pharmacopeial, CDSCO, and WHO advisory panels
• Award-winning mentorship, guiding post-graduates and PhD scholars with more than 90% placement in global pharma and academia.
• Interdisciplinary collaborations spanning nanomedicine, biotherapeutics, green manufacturing, and regulatory science

United by the motto Invent Insure Introduce, our faculty cultivate a learning environment where rigorous science meets real-world impact nurturing the next generation of formulation scientists and regulatory leaders.

Academic Programs:

The Department of Pharmaceutics delivers a tightly focused, research-intensive academic portfolio that spans postgraduate training through to doctoral:

Every learner benefit from close mentoring by our esteemed faculty members and direct hands-on time with cutting-edge equipment. Coursework is interwoven with translational projects so graduates leave not only with strong theoretical foundations but with real-world dossiers, pilot-scale data packs and regulatory-ready documentation that accelerate their transition into industry, research or entrepreneurial ventures.

In short, our programmes are engineered to move students "From Bench to Bedside": inventing smarter dosage forms, ensuring uncompromising quality, and introducing compliant products to the global marketplace.

State-of-the-Art Facilities:

Our laboratories, give students and researchers everything they need to turn ideas into industry-ready products:

• Nanomedicine & Nano-formulation Hub: A dedicated suite with cryo-TEM, zeta-sizer, micro-fluidic nano precipitators and flow cytometer for designing and characterising advanced nano-carriers.
• Centre of Excellence in Regulatory Sciences: Hosts regular eCTD training workshops and houses the PharmaReady eCTD system, ensuring our graduates are fluent in global submission standards. Partnering with Biocon Academy for the Global Regulatory Affairs Programme.
• 3-D Printing & Bioprinting Facility: Equipped with a multi-material 3-D printer for rapid prototyping of dosage forms and tissue-mimetic test beds.
• Digital & Simulation Suites: 210 networked desktops running Design-Expert, BIOVIA Discovery Studio and an AR/VR "virtual plant", letting learners rehearse every step of product development in a risk-free environment.
• Comprehensive Library & E-resources: 1,500 + e-journals, 13,200 print volumes and 24/7 off-campus access through the KOHA-powered JSS Library portal.

Together, these resources create a seamless pipeline- from molecular design, through regulatory documentation, to pilot-scale manufacture-where theory quickly becomes practical skill.

Research Focus Areas:

Our faculty, students, and industry partners work at the intersection of formulation science, analytics, and regulatory policy. Current flagship themes include:

• Targeted Nanomedicine: Ligand-decorated lipid, polymer, and graphene nanocarriers engineered to cross the blood - brain barrier or home to tumours, carrying small molecules, peptides, siRNA, or mRNA payloads.
• Smart Polymeric & 3-D-Printed Dosage Forms: Stimuli-responsive hydrogels, implants, and patient-specific tablets fabricated via hot-melt extrusion and multi-material 3-D printing for on-demand or site-specific release.
• Translational Biopharmaceutics & Bioavailability Enhancement: In-silico BPPK modelling, IVIVC studies, and novel absorption promoters to maximise systemic exposure while minimising dose and variability.
• Quality & Regulatory Science: Comparative analysis of Indian, US-FDA, EMA, and ICH guidelines; eCTD dossier generation; and risk-based Quality-by-Design (QbD) frameworks that feed directly into our Centre of Excellence for Regulatory Affairs.
• AI-Enabled Formulation & Process Optimisation Machine-learning models built in Design-Expert and BIOVIA Discovery Studio, plus digital-twin simulations that predict critical quality attributes and accelerate scale-up.

Together, these focus areas ensure that the Department of Pharmaceutics stays at the cutting edge-transforming inventive concepts into safe, effective, and compliant therapies for global healthcare.

Research Excellence:

Over the last five years, our department has emerged as a national leader in pharmaceutics:

• High-impact publications: We have produced more than 500 SCI-indexed papers (cumulative impact factor = 1000; h-index growth from 27 to 34), with articles in Advanced Drug Delivery Reviews, Journal of Controlled Release and International Journal of Pharmaceutics.
• Intellectual property: Faculty and student teams have 09 Granted patents and 10 published including a transferrin-tagged graphene nanoribbon carrier and a dual-payload nanogel - demonstrating a strong bench-to-patent pipeline.
• Competitive funding: Grants exceed Rs. 5 crore, spanning DST-SERB, DBT, ICMR, AICTE-MODROBS, and industry consultancies with Biocon, Natural Remedies, and global CRO partners.
• Collaborative networks: We co-publish and co-supervise projects with IIT-Bombay, NIPER-Hyderabad, Monash University, and King's College London, amplifying both reach and rigor.
• Recognition & awards: Faculty have secured Best thesis awards, World's Top 2% Scientists, and many more recognitions to our faculties and students.

This blend of peer-reviewed output, protected innovation, and diversified funding underlines our commitment to advancing pharmaceutical science and converting discoveries into therapies that improve global heal.

Publication and Placement Record:

Publication & Placement Record (Last 5 Years)- at a Glance

Graduate Output & Placement

Key recruiters: Biocon, Dr Reddy's, Syngene, Reliance Life Sciences, Natco, and emerging biotech start-ups (details in FIST Annexures).

The Department publishes nearly three high-impact papers every month, garners citations across premier drug-delivery journals. Parallel to this, almost nine in ten M .Pharm graduates and virtually all PhD holders secure R&D or academic positions each year. These twin outcomes-scholarly visibility and career readiness-validate the department's culture of rigorous research aligned with real-world pharmaceutical needs.